Iron Treatment After Heart Failure Shows Economic Benefits in Europe

A new economic analysis finds that giving iron supplements to heart failure patients at hospital discharge reduces costs and improves outcomes across European healthcare systems. The finding could shift treatment protocols and influence drug purchasing decisions for hospitals managing one of the most common chronic conditions.

Originaltitel: Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation